Clinical Trials · NCT00651326
Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Terminated
- Sponsor
- NCIC Clinical Trials Group
- Enrollment
- 48
- Start date
- Jun 2008
- Locations
- 13 sites, Canada
- Primary endpoint
- Disease-free survival